Genomictree Inc. (KOSDAQ:228760)

Genomictree Statistics

Total Valuation

Genomictree has a market cap or net worth of KRW 478.78 billion. The enterprise value is 404.02 billion.

Market Cap	478.78B
Enterprise Value	404.02B

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Genomictree has 24.27 million shares outstanding. The number of shares has increased by 0.88% in one year.

Current Share Class	24.27M
Shares Outstanding	24.27M
Shares Change (YoY)	+0.88%
Shares Change (QoQ)	-0.17%
Owned by Insiders (%)	15.87%
Owned by Institutions (%)	0.10%
Float	20.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	127.33
PB Ratio	4.15
P/TBV Ratio	4.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-44.96
EV / Sales	107.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-31.27

Financial Position

The company has a current ratio of 17.75, with a Debt / Equity ratio of 0.02.

Current Ratio	17.75
Quick Ratio	17.55
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-33.42

Financial Efficiency

Return on equity (ROE) is -7.62% and return on invested capital (ROIC) is -37.31%.

Return on Equity (ROE)	-7.62%
Return on Assets (ROA)	-5.62%
Return on Invested Capital (ROIC)	-37.31%
Return on Capital Employed (ROCE)	-9.71%
Weighted Average Cost of Capital (WACC)	4.67%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	10.21

Taxes

In the past 12 months, Genomictree has paid 11.47 million in taxes.

Income Tax	11.47M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.79% in the last 52 weeks. The beta is 0.07, so Genomictree's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	+15.79%
50-Day Moving Average	22,705.60
200-Day Moving Average	20,299.70
Relative Strength Index (RSI)	45.05
Average Volume (20 Days)	167,921

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genomictree had revenue of KRW 3.76 billion and -8.99 billion in losses. Loss per share was -374.00.

Revenue	3.76B
Gross Profit	699.00M
Operating Income	-11.30B
Pretax Income	-9.11B
Net Income	-8.99B
EBITDA	-10.23B
EBIT	-11.30B
Loss Per Share	-374.00

Balance Sheet

The company has 77.37 billion in cash and 2.37 billion in debt, with a net cash position of 75.00 billion or 3,090.61 per share.

Cash & Cash Equivalents	77.37B
Total Debt	2.37B
Net Cash	75.00B
Net Cash Per Share	3,090.61
Equity (Book Value)	115.31B
Book Value Per Share	4,776.24
Working Capital	74.46B

Cash Flow

In the last 12 months, operating cash flow was -10.19 billion and capital expenditures -2.73 billion, giving a free cash flow of -12.92 billion.

Operating Cash Flow	-10.19B
Capital Expenditures	-2.73B
Depreciation & Amortization	1.11B
Net Borrowing	-49.91M
Free Cash Flow	-12.92B
FCF Per Share	-532.37

Margins

Gross margin is 18.59%, with operating and profit margins of -300.47% and -238.98%.

Gross Margin	18.59%
Operating Margin	-300.47%
Pretax Margin	-242.38%
Profit Margin	-238.98%
EBITDA Margin	-272.15%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genomictree does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.88%
Shareholder Yield	-0.88%
Earnings Yield	-1.88%
FCF Yield	-2.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 14, 2018. It was a forward split with a ratio of 2.

Last Split Date	Sep 14, 2018
Split Type	Forward
Split Ratio	2

Scores

Genomictree has an Altman Z-Score of 49.29 and a Piotroski F-Score of 2.

Altman Z-Score	49.29
Piotroski F-Score	2